Synthesis and biological evaluation of a biotinylated paclitaxel with an extra-long chain spacer arm

ACS Medicinal Chemistry Letters

Volumn 3, Issue 9, 2012, Pages 745-748

  Lis, Lev G ^a   Smart, Mary A ^a   Luchniak, Anna ^b   Gupta, Mohan L ^b   Gurvich, Vadim J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

biotin; biotinylated; paclitaxel; taxol

Indexed keywords

BIOTIN; PACLITAXEL; PACLITAXEL DERIVATIVE; STREPTAVIDIN; TUBULIN;

ARTICLE; BIOTINYLATION; DRUG BINDING; DRUG BINDING SITE; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; MICROTUBULE; MICROTUBULE ASSEMBLY; PRIORITY JOURNAL;

EID: 84866433815     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml300149z     Document Type: Article

References (35)

1. Nicolaou, K. C.; Dai, W. M.; Guy, R. K. Chemistry and biology of Taxol Angew. Chem., Int. Ed. Engl. 1994, 33, 15
2. Zefirova, O. N.; Nurieva, E. V.; Ryzhov, A. N.; Zyk, N. V.; Zefirov, N. S. Taxol: Synthesis, bioactive conformations, and structure-activity relationships in its analogs Russ. J. Org. Chem. 2005, 41, 315
3. Wani, M. C.; Taylor, H. L.; Wall, M. E.; Coggon, P.; McPhail, A. T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia J. Am. Chem. Soc. 1971, 93, 2325
4. Hortobagyi, G. N.; Holmes, F. A.; Theriault, R. L.; Buzdar, A. U. Use of Taxol (Paclitaxel) in breast-cancer Oncology 1994, 51, 29
5. Huizing, M. T.; Misser, V. H. S.; Pieters, R. C.; Huinink, W. W. T.; Veenhof, C. H. N.; Vermorken, J. B.; Pinedo, H. M.; Beijnen, J. H. Taxanes-A new class of antitumor agents Cancer Invest. 1995, 13, 381
6. Suffness, M. Overview of paclitaxel research-Progress on many fronts. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chem, T. T.; Ojima, I.; Vyas, D. M., Eds.; American Chemical Society: Washington, DC, 1995; Vol. 583, p 1.
7. Gordaliza, M. Natural products as leads to anticancer drugs Clin. Transl. Oncol. 2007, 9, 767
8. Miller, K.; Neilan, B.; Sze, D. M. Y. Development of taxol and other endophyte produced anti-cancer agents Recent Pat. Anti-Cancer Drug Discovery 2008, 3, 14
9. Liu, E. H.; Qi, L. W.; Wu, Q.; Peng, Y. B.; Li, P. Anticancer agents derived from natural products Mini-Rev. Med. Chem. 2009, 9, 1547
10. Zhao, Y.; Fang, W. S.; Pors, K. Microtubule stabilising agents for cancer chemotherapy Expert Opin. Ther. Pat. 2009, 19, 607
11. Fauzee, N. J. S.; Dong, Z.; Wang, Y. L. Taxanes: Promising anti-cancer drugs Asian Pac. J. Cancer Prev. 2011, 12, 837
12. Gore, M. E.; Levy, V.; Rustin, G.; Perren, T.; Calvert, A. H.; Earl, H.; Thompson, J. M. Paclitaxel (Taxol) in relapsed and refractory ovarian-cancer-The UK and Eire experience Br. J. Cancer 1995, 72, 1016
13. Russell-Jones, G.; McTavish, K.; McEwan, J.; Rice, J.; Nowotnik, D. Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours J. Inorg. Biochem. 2004, 98, 1625
14. Luo, S.; Zhangsun, D.; Tang, K. Functional GNA expressed in Escherichia coli with high efficiency and its effect on Ceratovacuna lanigera Zehntner Appl. Microbiol. Biotechnol. 2005, 69, 184
15. Bildstein, L.; Dubernet, C.; Couvreur, P. Prodrug-based intracellular delivery of anticancer agents Adv. Drug Delivery Rev. 2011, 63, 3
16. Yellepeddi, V. K.; Kumar, A.; Palakurthi, S. Biotinylated poly(amido)amine (PAMAM) dendrimers as carriers for drug delivery to ovarian cancer cells in vitro Anticancer Res. 2009, 29, 2933
17. Yellepeddi, V. K.; Kumar, A.; Maher, D. M.; Chauhan, S. C.; Vangara, K. K.; Palakurthi, S. Biotinylated PAMAM dendrimers for intracellular delivery of cisplatin to ovarian cancer: Role of SMVT Anticancer Res. 2011, 31, 897
18. Xiong, X. Y.; Gong, Y. C.; Li, Z. L.; Li, Y. P.; Guo, L. Active targeting behaviors of biotinylated pluronic/poly(lactic acid) nanoparticles in vitro through three-step biotin-avidin interaction J. Biomater. Sci., Polym. Ed. 2011, 22, 1607
19. Inverarity, L. A.; Viguier, R. F. H.; Cohen, P.; Hulme, A. N. Biotinylated anisomycin: A comparison of classical and "Click" chemistry approaches Bioconjugate Chem. 2007, 18, 1593
20. Jordan, M. A. Mechanism of action of antitumor drugs that interact with microtubules and tubulin Curr. Med. Chem.: Anti-Cancer Agents 2002, 2, 1
21. Rao, S.; Horwitz, S. B.; Ringel, I. Direct photoaffinity-labeling of tubulin with taxol J. Natl. Cancer Inst. 1992, 84, 785
22. Jordan, M. A.; Toso, R. J.; Thrower, D.; Wilson, L. Mechanism of miotic block and inhibition of cell-proliferation by taxol at low concentrations Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 9552
23. Derry, W. B.; Wilson, L.; Jordan, M. A. Substoichiometric binding of taxol supresses microtubule dynamics Biochemistry (Moscow) 1995, 34, 2203
24. Ross, J. L.; Fygenson, D. K. Mobility of taxol in microtubule bundles Biophys. J. 2003, 84, 3959
25. Byrd, C. A.; Bornmann, W.; Erdjument-Bromage, H.; Tempst, P.; Pavletich, N.; Rosen, N.; Nathan, C. F.; Ding, A. Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharide Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 5645
26. Sambaiah, T.; King, K. Y.; Tsay, S. C.; Mei, N. W.; Hakimclahi, S.; Lai, Y. K.; Lieu, C. H.; Hwu, J. R. Synthesis and immunofluorescence assay of a new biotinylated paclitaxel Eur. J. Med. Chem. 2002, 37, 349
27. Guy, R. K.; Scott, Z. A.; Sloboda, R. D.; Nicolaou, K. C. Fluorescent taxoids Chem. Biol. 1996, 3, 1021
28. Ohtsu, H.; Nakanishi, Y.; Bastow, K. F.; Lee, F. Y.; Lee, K. H. Antitumor agents 216. Synthesis and evaluation of paclitaxel-camptothecin conjugates as novel cytotoxic agents Bioorg. Med. Chem. 2003, 11, 1851
29. Deutsch, H. M.; Glinski, J. A.; Hernandez, M.; Haugwitz, R. D.; Narayanan, V. L.; Suffness, M.; Zalkow, L. H. Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity J. Med. Chem. 1989, 32, 788
30. Rao, C. S.; Chu, J. J.; Liu, R. S.; Lai, Y. K. Synthesis and evaluation of C-14 -labelled and fluorescent-tagged paclitaxel derivatives as new biological probes Bioorg. Med. Chem. 1998, 6, 2193
31. Efthimiadou, E. K.; Katsarou, M. E.; Fardis, M.; Zikos, C.; Pitsinos, E. N.; Kazantzis, A.; Leondiadis, L.; Sagnou, M.; Vourloumis, D. Synthesis and characterization of novel natural product-Gd(III) MRI contrast agent conjugates Bioorg. Med. Chem. Lett. 2008, 18, 6058
32. Ruijtenbeek, R.; Kruijtzer, J. A. W.; van de Wiel, W.; Fischer, M. J. E.; Fluck, M.; Redegeld, F. A. M.; Liskamp, R. M. J.; Nijkamp, F. P. Peptoidpeptide hybrids that bind Syk SH2 domains involved in signal transduction ChemBioChem 2001, 2, 171
33. McNair, R. J. Catalytic deprotection-DEPRO catalyst kit/catalytic deprotection Aldrich ChemFiles 2009, 9, 21
34. Dubois, J.; Legoff, M. T.; Guerittevoegelein, F.; Guenard, D.; Tollon, Y.; Wright, M. Fluorescent and biotinylated analogs of docetaxel - synthesis and biological evaluation Bioorg. Med. Chem. 1995, 3, 1357
35. Kar, A. K.; Braun, P. D.; Wandless, T. J. Synthesis and evaluation of daunorubicin-paclitaxel dimers Bioorg. Med. Chem. Lett. 2000, 10, 261